Exponent's second quarter results showed an increase in total revenues and revenues before reimbursements. Net income also increased, and the company saw growth across several industries, including consumer products, chemicals, automotive, and life sciences.
Total revenues increased by 8.7% to $130.3 million compared to the second quarter of 2021.
Revenues before reimbursements increased by 5.1% to $118.2 million compared to the second quarter of 2021.
Net income increased to $25.8 million, or $0.49 per diluted share, compared to $25.4 million, or $0.48 per diluted share, in the same period of 2021.
EBITDA increased to $37.1 million, or 31.4% of net revenues.
Exponent anticipates continued growth and momentum in hiring, expecting it to accelerate in the second half of the year. The company is maintaining its revenue guidance and improving its margin guidance for the full year 2022.